Capitaux Propres Et Réserves Changement Date
AbbVie USD -5.94B 721M 2026-06
Aena EUR 8.86B 1.03B 2026-06
Alcon AG USD 22.13B 99M 2026-03
Almirall EUR 1.53B 43.26M 2026-06
Amarin USD 443.62M 5.8M 2026-06
Amgen USD 11.69B 2.5B 2026-06
AstraZeneca USD 50.3B 2.96B 2026-06
Bayer EUR 28.85B 2.9B 2026-03
Biogen USD 18.85B 196.3M 2026-06
BMW EUR 99.56B 3.86B 2026-03
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Eli Lilly USD 33.88B 2.68B 2026-06
Essilor EUR 39.22B 329M 2026-06
Fresenius EUR 19.7B 766M 2026-06
Fresenius Medical Care EUR 14.2B 13.95B 2026-03
Genmab DKK 5.96B 275M 2026-06
Gilead Sciences USD 11.74B 11.77B 2026-06
GlaxoSmithKline GBP 17.64B 223M 2026-06
GRIFOLS EUR 7.98B 2.52B 2026-06
Hikma Pharmaceutical USD 2.59B 42M 2025-12
J&J USD 84.97B 3.78B 2026-06
Lakefront Biotherapeutics EUR 3.25B 17.5M 2026-03
Lonza CHF 9.13B 513M 2025-12
Mercedes-Benz AG EUR 91.78B 2.42B 2026-06
Merck EUR 29.74B 1.15B 2026-03
Merck USD 41.93B 3.94B 2026-06
Novartis USD 41.95B 3.02B 2026-06
Novo Nordisk DKK 221.28B 18.21B 2026-06
Orion EUR 1.27B 146.5M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Philips EUR 11.48B 84M 2026-06
Recordati EUR 2.13B 70.34M 2026-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
Sanofi EUR 69.57B 3.24B 2026-06
Sanofi EUR 73.14B 1.43B 2026-03
SAP EUR 44.74B 117M 2026-06
UCB EUR 10.87B 1.18B 2025-12
Vinci EUR 30.59B 3.74B 2026-06
Volkswagen EUR 176.16B 2.16B 2026-03